NO20016025L - Induksjon av vaskul¶r endotelvekstfaktor (VEGF) ved serin/treoninproteinkinase Akt - Google Patents

Induksjon av vaskul¶r endotelvekstfaktor (VEGF) ved serin/treoninproteinkinase Akt

Info

Publication number
NO20016025L
NO20016025L NO20016025A NO20016025A NO20016025L NO 20016025 L NO20016025 L NO 20016025L NO 20016025 A NO20016025 A NO 20016025A NO 20016025 A NO20016025 A NO 20016025A NO 20016025 L NO20016025 L NO 20016025L
Authority
NO
Norway
Prior art keywords
vegf
serine
induction
growth factor
protein kinase
Prior art date
Application number
NO20016025A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016025D0 (no
Inventor
Kun Guo
Yuri D Ivashchenko
Kenneth L Clark
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of NO20016025D0 publication Critical patent/NO20016025D0/no
Publication of NO20016025L publication Critical patent/NO20016025L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20016025A 1999-06-11 2001-12-10 Induksjon av vaskul¶r endotelvekstfaktor (VEGF) ved serin/treoninproteinkinase Akt NO20016025L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13872499P 1999-06-11 1999-06-11
GB9926058 1999-11-03
PCT/US2000/015098 WO2000077190A2 (en) 1999-06-11 2000-06-01 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt

Publications (2)

Publication Number Publication Date
NO20016025D0 NO20016025D0 (no) 2001-12-10
NO20016025L true NO20016025L (no) 2002-02-08

Family

ID=26316052

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016025A NO20016025L (no) 1999-06-11 2001-12-10 Induksjon av vaskul¶r endotelvekstfaktor (VEGF) ved serin/treoninproteinkinase Akt

Country Status (17)

Country Link
EP (1) EP1187911A2 (zh)
JP (1) JP2003530818A (zh)
KR (1) KR20020012270A (zh)
CN (1) CN1360629A (zh)
AU (1) AU773450B2 (zh)
BR (1) BR0011503A (zh)
CA (1) CA2376630A1 (zh)
CZ (1) CZ20014444A3 (zh)
HK (1) HK1041500A1 (zh)
HU (1) HUP0201663A3 (zh)
IL (1) IL146730A0 (zh)
MX (1) MXPA01012748A (zh)
NO (1) NO20016025L (zh)
NZ (1) NZ516054A (zh)
PL (1) PL352859A1 (zh)
SI (1) SI20978A (zh)
WO (1) WO2000077190A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
DE60039677D1 (de) * 1999-03-19 2008-09-11 Aventis Pharma Inc Akt-3 nukleinsäure, polypeptide und deren verwendung
CN100357433C (zh) * 1999-04-16 2007-12-26 耶鲁大学 可用于基因治疗和治疗性筛选的eNOS突变
US6187586B1 (en) * 1999-12-29 2001-02-13 Isis Pharmaceuticals, Inc. Antisense modulation of AKT-3 expression
US20010038842A1 (en) * 2000-03-02 2001-11-08 Marc Achen Methods for treating various cancers expressing vascular endothelial growth factor D, for screening for a neoplastic disease and for maintaining vascularization of tissue
US20020102260A1 (en) 2000-03-02 2002-08-01 Marc Achen Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
US7531318B2 (en) 2004-08-20 2009-05-12 Board Of Regents, The University Of Texas System Screening of agents for activity against ischemic myocardial insults

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039677D1 (de) * 1999-03-19 2008-09-11 Aventis Pharma Inc Akt-3 nukleinsäure, polypeptide und deren verwendung

Also Published As

Publication number Publication date
KR20020012270A (ko) 2002-02-15
HUP0201663A3 (en) 2005-01-28
JP2003530818A (ja) 2003-10-21
CN1360629A (zh) 2002-07-24
PL352859A1 (en) 2003-09-08
CA2376630A1 (en) 2000-12-21
IL146730A0 (en) 2002-07-25
BR0011503A (pt) 2002-03-05
WO2000077190A2 (en) 2000-12-21
AU5175800A (en) 2001-01-02
EP1187911A2 (en) 2002-03-20
NZ516054A (en) 2004-04-30
HK1041500A1 (zh) 2002-07-12
CZ20014444A3 (cs) 2002-05-15
HUP0201663A2 (en) 2002-08-28
AU773450B2 (en) 2004-05-27
SI20978A (sl) 2003-02-28
NO20016025D0 (no) 2001-12-10
WO2000077190A3 (en) 2001-04-12
MXPA01012748A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
FR13C0003I2 (fr) Inhibiteurs cycliques de proteine tyrosine kinase
NO20032827D0 (no) Fremgangsmåte for fremstilling av det anticholinerge middel tiotropiumbromid
DE60033030D1 (de) Verwendung von gegen cd20 gerichteten antikörpern zur behandlung der graft versus host krankheit
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20013185D0 (no) Fremgangsmåte ved fremstilling av citalopram
NO20033684D0 (no) Behandling av motstandsdyktige tumorer ved anvendelse av epotilonderivater
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
NO20023553D0 (no) Fremgangsmåte for epoksydering av olefiner
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20013569L (no) Fremgangsmate ved fremstilling av L-fenylephrine-hydroklorid
NO20016025L (no) Induksjon av vaskul¶r endotelvekstfaktor (VEGF) ved serin/treoninproteinkinase Akt
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
FI19992660A (fi) Kondensaattoreiden jännitteenjaon tasauskytkentä
NO20015316L (no) Optimalisering av fermenteringsprosess
NO20034003L (no) Fremgangsmåte for fremstilling av imidazolforbindelser
NO20013818L (no) Mikrobiell fremgangsmåte for fremstilling av pravastatin
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
NO20015469L (no) Fremgangsmåte for behandling av petroleumsyrer
NO20014222L (no) Fremgangsmåte for behandling av COPD
DK1169260T3 (da) Løfteapparat til lag af bakkestabler
NO20001490L (no) FremgangsmÕte ved deteksjon av sulfatreduserende bakterier
NO20003440L (no) Fremgangsmåte ved behandling av faststoffer
FI990042A (fi) Menetelmä viherlipeän piipitoisuuden alentamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application